Brief Report: Phase II Clinical Trial of Atezolizumab in Advanced Nonsmall Cell Lung Cancer Patients Previously Treated With PD-1-Directed Therapy.

IF 3.3 3区医学 Q2 ONCOLOGY

Clinical lung cancer Pub Date : 2024-10-30 DOI:10.1016/j.cllc.2024.10.014

Dylan Fortman, Hong Wang, Robert VanderWeele, Terry Evans, James G Herman, John Rhee, Vincent Reyes, Brian McLaughlin, Antoinette Wozniak, Ashwin Somasundaram, Tarek Mekhail, Mark A Socinski, Katja Schulze, Liza C Villaruz

引用次数: 0

查看原文本刊更多论文

简要报告：曾接受 PD-1 导向疗法治疗的晚期非小细胞肺癌患者的 Atezolizumab II 期临床试验。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical lung cancer 医学-肿瘤学

CiteScore

7.00

自引率

2.80%

发文量

159

审稿时长

24 days

期刊介绍： Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.